Pfizer drug shows unprecedented survival in colorectal cancer

The latest stories trending on MedCity News.

Editor's Pick

Top Story Precision Pfizer Drug Leads to 'Unprecedented' Survival in Colorectal Cancer, Data at ASCO Show Pfizer drug Braftovi achieved statistically significant and clinically meaningful improvement in overall survival for colorectal cancer patients in a Phase 3 clinical trial. The results will be presented Friday during the annual meeting of the American Society of Clinical Oncology. Sponsored Attention Data Scientists and Clinicians! Presented by Society of Critical Care Medicine Address real-world critical care issues and improve patient care at the Society of Critical Care Medicine's Datathon. Attend July 19-20 near Chicago to collaborate and revolutionize healthcare with some of the most talented and innovative clinical and data professionals. Sponsorship opportunities are available. Register now.

Featured News

Astellas Stays Competitive in Hot Gut Cancer Target, Paying $130M to License Evopoint Drug Astellas Pharma gets global rights to an Evopoint Biosciences antibody drug conjugate that targets Claudin 18.2. Last year, Astellas's antibody drug Vyloy became the first FDA-approved therapy for this target. 4 Notable Health Tech Funding Announcements in May Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds. Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs May has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, the American Medical Association and TigerConnect named new CEOs, and Google and UnitedHealth Group have seen key executives leave their roles. There were also layoffs at organizations including Devoted Health and New York-Presbyterian. MedCity FemFwd: Investment Trends In Women's Health In this episode, we're joined by Margaret Malone, principal of Flare Capital Partners. She discusses the investment trends she's following in the women's health space and advice she has for startups. Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences By treating model governance as a proactive, integral part of operations rather than a box to check after the fact, life sciences organizations can uphold compliance, better allocate their resources, and gain a competitive edge. Workplace Violence Prevention in 2025 Workplace violence prevention is an ongoing and organic process. Federal and state regulations change frequently, so employers may consider regularly reviewing and updating their prevention plans and training programs on a scheduled timeline.

Video   How employers are managing GLP-1s At MedCity INVEST, Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, discussed the strategies he's seeing employers implement around GLP-1s. He noted that many employers are taking a "middle ground" approach—such as covering the drugs for individuals with higher BMIs—and are also providing lifestyle support.

Sponsored The 6 Most Affordable Workflow Optimization Tools for Radiology Presented by Candelis Radiologists today face a surge in imaging volume and pressure to produce fast, accurate reports. Workflow optimization is about delivering the right results at the right time with less friction. Learn More

Resources

MedCity Pivot Podcast: Precision Medicine with the CEO of Helix In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe